Dr. Najat C. Daw
Claim this profileM D Anderson Cancer Center
Expert in Cancer
Expert in Lymphoma
50 reported clinical trials
103 drugs studied
About Najat C. Daw
Education:
- Obtained MD from the University of Jordan Faculty of Medicine.
- Completed Residency in Internal Medicine at the University of Texas Health Science Center at Houston.
- Undertook Fellowship in Hematology and Medical Oncology at The University of Texas MD Anderson Cancer Center.
Experience:
- Currently serves as an Associate Professor in the Department of Leukemia at MD Anderson Cancer Center.
Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Lymphoma
Global LeaderStage I
Stage II
BCR-ABL1 fusion positive
Affiliated Hospitals
Clinical Trials Najat C. Daw is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
More about Najat C. Daw
Clinical Trial Related4 years of experience running clinical trials · Led 50 trials as a Principal Investigator · 24 Active Clinical TrialsTreatments Najat C. Daw has experience with
- Cyclophosphamide
- Radiation Therapy
- Vincristine Sulfate
- Etoposide
- Doxorubicin Hydrochloride
- Methotrexate
Breakdown of trials Najat C. Daw has run
Cancer
Lymphoma
Benign Glioma
Osteosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Najat C. Daw specialize in?
Najat C. Daw focuses on Cancer and Lymphoma. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Najat C. Daw currently recruiting for clinical trials?
Yes, Najat C. Daw is currently recruiting for 21 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Najat C. Daw has studied deeply?
Yes, Najat C. Daw has studied treatments such as Cyclophosphamide, Radiation Therapy, Vincristine Sulfate.
What is the best way to schedule an appointment with Najat C. Daw?
Apply for one of the trials that Najat C. Daw is conducting.
What is the office address of Najat C. Daw?
The office of Najat C. Daw is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.